Skip to main content
Premium Trial:

Request an Annual Quote

Carna Acquires Market Rights to CrystalGenomics Kinase Crystallization Offerings

NEW YORK, Feb. 21 (GenomeWeb News) - Carna Biosciences has acquired the exclusive worldwide rights to sell CrystalGenomics' kinase crystallization-related products and services, the companies said today.

Specific terms of the deal were not disclosed.

Carna, which is based in Japan, and CrystalGenomics, which is based on Korea, have been jointly researching kinase inhibitors since forming an alliance in June 2004.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.